Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study

被引：1

作者：

Stolbrink, Marie ^{[1
,2
]}

Ozoh, Obianuju B. ^{[3
,4
]}

Halpin, David M. G. ^{[5
]}

Nightingale, Rebecca ^{[2
]}

Meghji, Jamilah ^{[6
]}

Plum, Catherine ^{[7
]}

Allwood, Brian William ^{[8
,9
]}

Jayasooriya, Shamanthi ^{[10
]}

Mortimer, Kevin ^{[11
,12
,13
]}

机构：

[1] Stellenbosch Univ, Polit Sci, Stellenbosch, South Africa

[2] Univ Liverpool Liverpool Sch Trop Med, Clin Sci, Liverpool L3 5QA, England

[3] Univ Lagos, Coll Med, Dept Med, Lagos, Nigeria

[4] Lagos Univ Teaching Hosp, Dept Med, Surulere, Nigeria

[5] Royal Devon & Exeter Hosp, Dept Respirol, Exeter, England

[6] Imperial Coll London, London, England

[7] Univ Hosp Morecambe Bay NHS Trust, Kendal, England

[8] Tygerberg Acad Hosp, Dept Pulmonol, Cape Town, South Africa

[9] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Pulmonol, Cape Town, South Africa

[10] Univ Sheffield, Acad Unit Primary Care, Sheffield, England

[11] Univ Cambridge, Dept Med, Cambridge, England

[12] Univ KwaZulu Natal, Coll Hlth Sci, Dept Med, Durban, South Africa

[13] Liverpool Univ Hosp NHS Fdn Trust, Liverpool, England

来源：

THORAX | 2024年 / 79卷 / 07期

基金：

英国惠康基金; 英国医学研究理事会;

关键词：

Asthma; COPD Pharmacology; Asthma Pharmacology; Health Economist; HEALTH; ASTHMA;

D O I：

10.1136/thorax-2023-221349

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Contemporary data on the availability, cost and affordability of essential medicines for chronic respiratory diseases (CRDs) across low-income and middle-income countries (LMICs) are missing, despite most people with CRDs living in LMICs. Cross-sectional data for seven CRD medicines in pharmacies, healthcare facilities and central medicine stores were collected from 60 LMICs in 2022-2023. Medicines for symptomatic relief were widely available and affordable, while preventative treatments varied widely in cost, were less available and largely unaffordable. There is an urgent need to address these issues if the Sustainable Development Goal 3 is to be achieved for people with asthma by 2030.

引用

页码：676 / 679

页数：4

共 50 条

[1] The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review
Stolbrink, Marie
Thomson, Helen
Hadfield, Ruth M.
Ozoh, Obianuju B.
Nantanda, Rebecca
Jayasooriya, Shamanthi
Allwood, Brian
Halpin, David M. G.
Salvi, Sundeep
de Oca, Maria Montes
Mortimer, Kevin
Rylance, Sarah
LANCET GLOBAL HEALTH, 2022, 10 (10): : E1423 - E1442
[2] The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries
Mendis, Shanthi
Fukino, Keiko
Cameron, Alexandra
Laing, Richard
Filipe, Antonio, Jr.
Khatib, Oussama
Leowski, Jerzy
Ewen, Margaret
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2007, 85 (04) : 279 - 288
[3] Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study
Chow, Clara K.
Ramasundarahettige, Chinthanie
Hu, Weihong
AlHabib, Khalid F.
Avezum, Alvaro, Jr.
Cheng, Xiaoru
Chifamba, Jephat
Dagenais, Gilles
Dans, Antonio
Egbujie, Bonaventure A.
Gupta, Rajeev
Iqbal, Romaina
Ismail, Noorhassim
Keskinler, Mirac V.
Khatib, Rasha
Kruger, Lanthe
Kumar, Rajesh
Lanas, Fernando
Lear, Scott
Lopez-Jaramillo, Patricio
McKee, Martin
Mohammadifard, Noushin
Mohan, Viswanathan
Mony, Prem
Orlandini, Andres
Rosengren, Annika
Vijayakumar, Krishnapillai
Wei, Li
Yeates, Karen
Yusoff, Khalid
Yusuf, Rita
Yusufali, Afzalhussein
Zatonska, Katarzyna
Zhou, Yihong
Islam, Shariful
Corsi, Daniel
Rangarajan, Sumathy
Teo, Koon
Gerstein, Hertzel C.
Yusuf, Salim
LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (10): : 798 - 808
[4] Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
Chow, Clara Kayei
Nguyen, Tu Ngoc
Marschner, Simone
Diaz, Rafael
Rahman, Omar
Avezum, Alvaro
Lear, Scott A.
Teo, Koon
Yeates, Karen E.
Lanas, Fernando
Li, Wei
Hu, Bo
Lopez-Jaramillo, Patricio
Gupta, Rajeev
Kumar, Rajesh
Mony, Prem K.
Bahonar, Ahmad
Yusoff, Khalid
Khatib, Rasha
Kazmi, Khawar
Dans, Antonio L.
Zatonska, Katarzyna
Alhabib, Khalid F.
Kruger, Iolanthe Marike
Rosengren, Annika
Gulec, Sadi
Yusufali, Afzalhussein
Chifamba, Jephat
Rangarajan, Sumathy
McKee, Martin
Yusuf, Salim
BMJ GLOBAL HEALTH, 2020, 5 (11):
[5] Insulin prices, availability and affordability in 13 low-income and middle-income countries
Ewen, Margaret
Joosse, Huibert-Jan
Beran, David
Laing, Richard
BMJ GLOBAL HEALTH, 2019, 4 (03):
[6] The availability, cost and affordability of essential medicines for asthma and COPD in low- and middle-income countries: A systematic review
Stolbrink, M.
Thomson, H.
Hadfield, R. M.
Ozoh, O. B.
Nantanda, R.
Jayasooria, S.
Allwood, B.
Halpin, D. M.
Salvi, S.
De Oca, M. Montes
Mortimer, K.
Rylance, S.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[7] The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries
Zaheer-Ud-Din Babar
Charon Lessing
Cécile Mace
Karen Bissell
PharmacoEconomics, 2013, 31 : 1063 - 1082
[8] The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries
Babar, Zaheer-Ud-Din
Lessing, Charon
Mace, Cecile
Bissell, Karen
PHARMACOECONOMICS, 2013, 31 (11) : 1063 - 1082
[9] Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Khatib, Rasha
Mckee, Martin
Shannon, Harry
Chow, Clara
Rangarajan, Sumathy
Teo, Koon
Wei, Li
Mony, Prem
Mohan, Viswanathan
Gupta, Rajeev
Kumar, Rajesh
Vijayakumar, Krishnapillai
Lear, Scott A.
Diaz, Rafael
Avezum, Alvaro
Lopez-Jaramillo, Patricio
Lanas, Fernando
Yusoff, Khalid
Ismail, Noorhassim
Kazmi, Khawar
Rahman, Omar
Rosengren, Annika
Monsef, Nahed
Kelishadi, Roya
Kruger, Annamarie
Puoane, Thandi
Szuba, Andrzej
Chifamba, Jephat
Temizhan, Ahmet
Dagenais, Gilles
Gafni, Amiram
Yusuf, Salim
LANCET, 2016, 387 (10013): : 61 - 69
[10] The availability of essential medicines for cardiovascular diseases in low- and middle-income countries: A case study of Bangladesh
Uddin, Md Jamal
Hakim, Shariful
Chowdhury, Muhammad Abdul Baker
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 174 - 174

← 1 2 3 4 5 →